VAV1 Human

Vav 1 Guanine Nucleotide Exchange Factor Human Recombinant
Cat. No.
BT29471
Source
Escherichia Coli.
Synonyms
Vav 1 Guanine Nucleotide Exchange Factor, VAV, Vav 1 Oncogene, Proto-Oncogene Vav.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 85% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

VAV1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 400 amino acids (189-565a.a) and having a molecular mass of 46.8kDa.
VAV1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
VAV1, a member of the VAV gene family, functions as a guanine nucleotide exchange factor (GEF) for Rho family GTPases. It plays a critical role in hematopoiesis, particularly in the development and activation of T cells and B cells. VAV1 interacts specifically with Nef proteins from HIV-1 and possesses an SH2 domain, suggesting its potential role as a substrate for tyrosine kinases. Its expression is restricted to cells of hematopoietic origin, including those in the erythroid, lymphoid, and myeloid lineages. Notably, VAV1 has been implicated in diseases such as cherubism and HIV-1 infection.
Description
Recombinant human VAV1, expressed in E. coli, is a non-glycosylated polypeptide chain with a molecular weight of 46.8 kDa. It encompasses amino acids 189-565 and includes a 23-amino acid His-tag at the N-terminus. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
A clear, sterile-filtered solution.
Formulation
VAV1 protein solution at a concentration of 0.25 mg/ml in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 30% glycerol, and 2 mM DTT.
Stability
For short-term storage (up to 4 weeks), the product should be stored at 4°C. For extended storage, freezing at -20°C is recommended. To ensure long-term stability, the addition of a carrier protein (0.1% HSA or BSA) is advised. Repeated freeze-thaw cycles should be avoided.
Purity
Purity exceeds 85% as determined by SDS-PAGE analysis.
Synonyms
Vav 1 Guanine Nucleotide Exchange Factor, VAV, Vav 1 Oncogene, Proto-Oncogene Vav.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMTEYDKR CCCLREIQQT EEKYTDTLGS IQQHFLKPLQ RFLKPQDIEI IFINIEDLLR VHTHFLKEMK EALGTPGAAN LYQVFIKYKE RFLVYGRYCS QVESASKHLD RVAAAREDVQ MKLEECSQRA NNGRFTLRDL LMVPMQRVLK YHLLLQELVK HTQEAMEKEN LRLALDAMRD LAQCVNEVKR DNETLRQITN FQLSIENLDQ SLAHYGRPKI DGELKITSVE RRSKMDRYAF LLDKALLICK RRGDSYDLKD FVNLHSFQVR DDSSGDRDNK KWSHMFLLIE DQGAQGYELF FKTRELKKKW MEQFEMAISN IYPENATANG HDFQMFSFEE TTSCKACQML LRGTFYQGYR CHRCRASAHK ECLGRVPPCG

Product Science Overview

Introduction

Vav 1 Guanine Nucleotide Exchange Factor (VAV1) is a member of the VAV gene family. It plays a crucial role in various cellular processes, particularly in the immune system. VAV1 is a guanine nucleotide exchange factor (GEF) for Rho family GTPases, which are involved in actin cytoskeletal rearrangements and transcriptional alterations .

Structure and Function

VAV1 is a protein-coding gene that encodes a protein essential for hematopoiesis, the process of forming blood cellular components. It is involved in the development and activation of T-cells and B-cells, which are critical components of the adaptive immune system . The protein interacts with several other proteins, facilitating signal transduction pathways that lead to cell differentiation and proliferation .

Mechanism of Action

As a GEF, VAV1 activates Rho family GTPases by facilitating the exchange of GDP for GTP. This activation triggers downstream signaling pathways that result in changes to the actin cytoskeleton, which is vital for cell movement, shape, and division . VAV1 also plays a role in transcriptional regulation, influencing gene expression patterns that are crucial for immune responses .

Clinical Significance

VAV1 has been identified as a specific binding partner of Nef proteins from HIV-1. The interaction between VAV1 and Nef proteins initiates significant morphological changes, cytoskeletal rearrangements, and activation of the JNK/SAPK signaling cascade, leading to increased viral transcription and replication . Additionally, VAV1 is associated with various diseases, including immunodeficiency and certain types of cancer .

Research and Applications

Recombinant VAV1 proteins are used in research to study its role in immune cell signaling and its interactions with other proteins. These studies help in understanding the molecular mechanisms underlying immune responses and the development of therapeutic strategies for diseases involving VAV1 .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.